Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Douglas Taylor

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Ovarian Neoplasms

Anatomy

Chemicals & Drugs

Phenomena

Western Blotting

Physiology

Procedures

Case-Control Studies

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
35
Gercel-Taylor, Cicek
17
Gerçel-Taylor, Ciçek
5
Yashar, Catheryn
3
Nakajima, Steven
3
Shields, Lisa
3
Gibb, RK
3
Bazzett, Lisa
3
Eblen, Abby
3
Eisenberg, Burton
2
Gatenby, RA
2
Boggess, Kim
2
Doering, DL
2
Shirwan, Haval
2
Singh, Narendra
2
Parker, Lynn

Sign-in to see all Coauthors

Publications

TOP 3
Taylor Douglas D; Gercel-Taylor Cicek; Parker Lynn P
Patient-derived tumor-reactive antibodies as diagnostic markers for ovarian cancer.
Parker Lynn P; Taylor Douglas D; Kesterson Sarah; Gercel-Taylor Cicek
Gene expression profiling in response to estradiol and genistein in ovarian cancer cells.
Rabinowits Guilherme; Gerçel-Taylor Cicek; Day Jamie M; Taylor Douglas D; Kloecker Goetz H
Exosomal microRNA: a diagnostic marker for lung cancer.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Douglas Taylor (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Taylor Douglas D; Gercel-Taylor Cicek; Parker Lynn P
Patient-derived tumor-reactive antibodies as diagnostic markers for ovarian cancer.
Gynecologic oncology 2009;115(1):112-20.
2009: Parker Lynn P; Taylor Douglas D; Kesterson Sarah; Gercel-Taylor Cicek
Gene expression profiling in response to estradiol and genistein in ovarian cancer cells.
Cancer genomics & proteomics 2009;6(3):189-94.
2009: Rabinowits Guilherme; Gerçel-Taylor Cicek; Day Jamie M; Taylor Douglas D; Kloecker Goetz H
Exosomal microRNA: a diagnostic marker for lung cancer.
Clinical lung cancer 2009;10(1):42-6.
2009: Ku Lowell T; Gercel-Taylor Cicek; Nakajima Steven T; Taylor Douglas D
Alterations of T cell activation signalling and cytokine production by postmenopausal estrogen levels.
Immunity & ageing : I & A 2009;6():1.
2008: Taylor Douglas D; Gercel-Taylor Cicek
MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer.
Gynecologic oncology 2008;110(1):13-21.
2007: Shondel S M; Helm C W; Gercel-Taylor C; Taylor D D
Differential expression of T-cell CD3-zeta chains in patients with cervical dysplasia before and after treatment.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2007;17(6):1278-82.
2007: Bohler Henry C; Gercel-Taylor Cicek; Lessey Bruce A; Taylor Douglas D
Endometriosis markers: immunologic alterations as diagnostic indicators for endometriosis.
Reproductive sciences (Thousand Oaks, Calif.) 2007;14(6):595-604.
2007: Abdallah Maher A; Abdullah Huda I; Kang Steven; Taylor Douglas D; Nakajima Steven T; Gercel-Taylor Cicek
Effects of the components of hormone therapy on matrix metalloproteinases in breast-cancer cells: an in vitro study.
Fertility and sterility 2007;87(4):978-81.
2006: Sabapatha Anuradha; Gercel-Taylor Cicek; Taylor Douglas D
Specific isolation of placenta-derived exosomes from the circulation of pregnant women and their immunoregulatory consequences.
American journal of reproductive immunology (New York, N.Y. : 1989) 2006;56(5-6):345-55.
2006: Akyol Sibel; Gercel-Taylor Cicek; Reynolds Lisa C; Taylor Douglas D
HSP-10 in ovarian cancer: expression and suppression of T-cell signaling.
Gynecologic oncology 2006;101(3):481-6.
2006: Toler Chris R; Taylor Douglas D; Gercel-Taylor Cicek
Loss of communication in ovarian cancer.
American journal of obstetrics and gynecology 2006;194(5):e27-31.
2006: Metzinger Daniel S; Taylor Douglas D; Gercel-Taylor Cicek
Induction of p53 and drug resistance following treatment with cisplatin or paclitaxel in ovarian cancer cell lines.
Cancer letters 2006;236(2):302-8.
2006: Taylor Douglas D; Bohler Henry C; Gercel-Taylor Cicek
Pregnancy-linked suppression of TcR signaling pathways by a circulating factor absent in recurrent spontaneous pregnancy loss (RPL).
Molecular immunology 2006;43(11):1872-80.
2006: Singh Narendra P; Miller Robert W; Yolcu Esma S; Kilinc Mehmet O; Oechsli Margaret; Huseby Rolf; Taylor Douglas D; Perry M Theresa; Larocca Renato V; Shirwan Haval
Primary tumor cells resected from cancer patients and decorated with a novel form of CD80 protein serve as effective antigen-presenting cells for the induction of autologous T cell immune responses ex vivo.
Human gene therapy 2006;17(3):334-46.
2006: Taylor Douglas D; Akyol Sibel; Gercel-Taylor Cicek
Pregnancy-associated exosomes and their modulation of T cell signaling.
Journal of immunology (Baltimore, Md. : 1950) 2006;176(3):1534-42.
2005: Yashar Catheryn M; Spanos William J; Taylor Douglas D; Gercel-Taylor Cicek
Potentiation of the radiation effect with genistein in cervical cancer cells.
Gynecologic oncology 2005;99(1):199-205.
2005: Gercel-Taylor Cicek; Scobee Jeremy J; Taylor Douglas D
Effect of chemotherapy on the mutation frequency of ovarian cancer cells at the HPRT locus.
Anticancer research 2005;25(3B):2113-7.
2005: Saxena Angela; Yashar Catheryn; Taylor Douglas D; Gercel-Taylor Cicek
Cellular response to chemotherapy and radiation in cervical cancer.
American journal of obstetrics and gynecology 2005;192(5):1399-403.
2005: Taylor D D; Gerçel-Taylor C
Tumour-derived exosomes and their role in cancer-associated T-cell signalling defects.
British journal of cancer 2005;92(2):305-11.
2004: Taylor Douglas D; Gercel-Taylor Cicek
Alterations in T-cell signal transduction molecules associated with recurrent spontaneous pregnancy loss.
Journal of reproductive immunology 2004;63(2):137-54.
2004: Taylor Douglas D; Edwards Robert P; Case Catherine R; Gerçel-Taylor Ciçek
Modulation of CD3-zeta as a marker of clinical response to IL-2 therapy in ovarian cancer patients.
Gynecologic oncology 2004;94(1):54-60.
2004: Gercel-Taylor Cicek; Feitelson Anna K; Taylor Douglas D
Inhibitory effect of genistein and daidzein on ovarian cancer cell growth.
Anticancer research 2004;24(2B):795-800.
2003: Taylor Douglas D; Gerçel-Taylor Ciçek; Lyons Karen S; Stanson Joanna; Whiteside Theresa L
T-cell apoptosis and suppression of T-cell receptor/CD3-zeta by Fas ligand-containing membrane vesicles shed from ovarian tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(14):5113-9.
2003: Lam Garrett K; Whitecar Paul W; Orton Susan; Boggess Kim A; Taylor Douglas D
Differential expression of TcR-CD3 zeta as evidence for altered immunoregulation in preeclamptic versus normotensive women.
American journal of obstetrics and gynecology 2003;189(3):843-7.
2003: Bazzett Lisa B; Magnus Manya; Taylor Douglas D; Gercel-Taylor Cicek
Urinary matrix metalloproteinases as a potential screening test for gynecologic malignancies.
Gynecologic oncology 2003;90(2):435-42.
2003: Singh Narendra P; Yolcu Esma S; Taylor Douglas D; Gercel-Taylor Cicek; Metzinger Daniel S; Dreisbach Stephen K; Shirwan Haval
A novel approach to cancer immunotherapy: tumor cells decorated with CD80 generate effective antitumor immunity.
Cancer research 2003;63(14):4067-73.
2002: Dehaven K; Taylor D D; Gercel-Taylor C
Comparison of serum vascular endothelial growth levels between patients with and without ovarian malignancies.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2002;12(6):715-9.
2002: Gercel-Taylor Cicek; O'Connor Siobhan M; Lam Garrett K; Taylor Douglas D
Shed membrane fragment modulation of CD3-zeta during pregnancy: link with induction of apoptosis.
Journal of reproductive immunology 2002;56(1-2):29-44.
2002: Eblen Abby C; Gerçel-Taylor Ciçek; Nakajima Steven T; Taylor Douglas D
Modulation of T-cell CD3-zeta chain expression in early pregnancy.
American journal of reproductive immunology (New York, N.Y. : 1989) 2002;47(3):167-73.
2002: Taylor Douglas D; Lyons Karen S; Gerçel-Taylor Ciçek
Shed membrane fragment-associated markers for endometrial and ovarian cancers.
Gynecologic oncology 2002;84(3):443-8.
2002: Taylor Douglas D; Sullivan Scott A; Eblen Abby C; Gercel-Taylor Cicek
Modulation of T-cell CD3-zeta chain expression during normal pregnancy.
Journal of reproductive immunology 2002;54(1-2):15-31.
2001: Whitecar P W; Boggess K A; McMahon M J; Thorp J M; Taylor D D
Altered expression of TCR-CD3zeta induced by sera from women with preeclampsia.
American journal of obstetrics and gynecology 2001;185(4):812-8.
2001: Manahan K J; Taylor D D; Gerçel-Taylor C
Clonal heterogeneity of p53 mutations in ovarian cancer.
International journal of oncology 2001;19(2):387-94.
2001: Gerçel-Taylor C; Ackermann M A; Taylor D D
Evaluation of cell proliferation and cell death based assays in chemosensitivity testing.
Anticancer research 2001;21(4A):2761-8.
2001: Taylor D D; Bender D P; Gerçel-Taylor C; Stanson J; Whiteside T L
Modulation of TcR/CD3-zeta chain expression by a circulating factor derived from ovarian cancer patients.
British journal of cancer 2001;84(12):1624-9.
2001: Bosscher J R; Gerçel-Taylor C; Watkins C S; Taylor D D
Epitope recognition by anti-cathepsin D autoantibodies in endometrial cancer patients.
Gynecologic oncology 2001;81(2):138-43.
2001: Gerçel-Taylor C; Bazzett L B; Taylor D D
Presence of aberrant tumor-reactive immunoglobulins in the circulation of patients with ovarian cancer.
Gynecologic oncology 2001;81(1):71-6.
2000: Eblen A C; Gercel-Taylor C; Shields L B; Sanfilippo J S; Nakajima S T; Taylor D D
Alterations in humoral immune responses associated with recurrent pregnancy loss.
Fertility and sterility 2000;73(2):305-13.
1999: Bazzett L B; Watkins C S; Gercel-Taylor C; Taylor D D
Modulation of proliferation and chemosensitivity by procathepsin D and its peptides in ovarian cancer.
Gynecologic oncology 1999;74(2):181-7.
1999: Jones J N; Gercel-Taylor C; Taylor D D
Altered cord serum lipid levels associated with small for gestational age infants.
Obstetrics and gynecology 1999;93(4):527-31.
1999: Makhija S; Taylor D D; Gibb R K; Gerçel-Taylor C
Taxol-induced bcl-2 phosphorylation in ovarian cancer cell monolayer and spheroids.
International journal of oncology 1999;14(3):515-21.
1998: Schneider C C; Gibb R K; Taylor D D; Wan T; Gerçel-Taylor C
Inhibition of endometrial cancer cell lines by mifepristone (RU 486).
Journal of the Society for Gynecologic Investigation 1998;5(6):334-8.
1998: Taylor D D; Gercel-Taylor C
Tumor-reactive immunoglobulins in ovarian cancer: diagnostic and therapeutic significance? (review).
Oncology reports 1998;5(6):1519-24.
1998: Katsanis W A; Shields L B; Spinnato J A; Gerçel-Taylor C; Taylor D D
Immune recognition of endometrial tumor antigens induced by multiparity.
Gynecologic oncology 1998;70(1):33-9.
1998: Yashar C M; Gerçel-Taylor C; Gibb R K; Weeks J W; Taylor D D
Identification of a unique form of p53 in human cord blood associated with the development of maternal autoantibodies.
American journal of reproductive immunology (New York, N.Y. : 1989) 1998;39(6):368-75.
1998: Chinni S R; Gerçel-Taylor C; Conner G E; Taylor D D
Cathepsin D antigenic epitopes identified by the humoral responses of ovarian cancer patients.
Cancer immunology, immunotherapy : CII 1998;46(1):48-54.
1997: Yashar C M; Taylor D D; Gibb R K; Gerçel-Taylor C
Lymphokine-activated killer (LAK)-mediated lysis of sequentially isolated ovarian cancer cell lines.
American journal of reproductive immunology (New York, N.Y. : 1989) 1997;38(6):431-7.
1997: Shields L B; Gerçel-Taylor C; Yashar C M; Wan T C; Katsanis W A; Spinnato J A; Taylor D D
Induction of immune responses to ovarian tumor antigens by multiparity.
Journal of the Society for Gynecologic Investigation 1997;4(6):298-304.
1997: Chinni S R; Falchetto R; Gercel-Taylor C; Shabanowitz J; Hunt D F; Taylor D D
Humoral immune responses to cathepsin D and glucose-regulated protein 78 in ovarian cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(9):1557-64.
1997: Gibb R K; Taylor D D; Wan T; O'Connor D M; Doering D L; Gerçel-Taylor C
Apoptosis as a measure of chemosensitivity to cisplatin and taxol therapy in ovarian cancer cell lines.
Gynecologic oncology 1997;65(1):13-22.
1996: Taylor D D; Gercel-Taylor C; Weese J L
Modulation of colon tumor oncogene expression by cancer patient-derived lipids.
Journal of surgical oncology 1996;63(1):46-51.
1996: Taylor D D; Gercel-Taylor C; Gall S A
Expression and shedding of CD44 variant isoforms in patients with gynecologic malignancies.
Journal of the Society for Gynecologic Investigation 1996;3(5):289-94.
1996: Gercel-Taylor C; Hoffman J P; Taylor D D; Owens K J; Eisenberg B L
Interleukin-2 activation of cytotoxic cells in postmastectomy seroma.
The Journal of surgical research 1996;61(1):89-96.
1996: Gwin J L; Gercel-Taylor C; Taylor D D; Eisenberg B
Role of LFA-3, ICAM-1, and MHC class I on the sensitivity of human tumor cells to LAK cells.
The Journal of surgical research 1996;60(1):129-36.
1996: Gercel-Taylor C; Doering D L; Kraemer F B; Taylor D D
Aberrations in normal systemic lipid metabolism in ovarian cancer patients.
Gynecologic oncology 1996;60(1):35-41.
1996: Gercel-Taylor C; Taylor D D
Effect of patient-derived lipids on in vitro expression of oncogenes by ovarian tumor cells.
Gynecologic and obstetric investigation 1996;42(1):42-8.
1993: Taylor D D; Gerçel-Taylor C; Fowler W C; Weese J L
Enhancement of antitumor effects of combined chemoimmunotherapy.
Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy 1993;13(2):91-7.
1992: Eisenberg B L; Lanciano R M; Nussbaum M L; Klein-Szanto A; Taylor D D
Intraoperative liver radiation after partial hepatectomy in a rat model.
The Journal of surgical research 1992;53(3):287-92.
1992: Yeung R S; Vollmer C; Taylor D D; Palazzo J; Weese J L
Intratumoral rIL2-based immunotherapy in B16 melanoma.
The Journal of surgical research 1992;53(2):203-10.
1992: Gatenby R A; Taylor D D; Ellison D J
Identification of a novel cell population in nonhealing wounds in tumors.
The Journal of surgical research 1992;53(2):188-94.
1992: Taylor D D; Gercel-Taylor C; Jenis L G; Devereux D F
Identification of a human tumor-derived lipolysis-promoting factor.
Cancer research 1992;52(4):829-34.
1991: Pelton J J; Taylor D D; Fowler W C; Taylor C G; Carp N Z; Weese J L
Lymphokine-activated killer cell suppressor factor in malignant effusions.
Archives of surgery (Chicago, Ill. : 1960) 1991;126(4):476-80.
1991: Eisenberg B L; Taylor D D; Weese J L
Aerosolized gamma-interferon and lipopolysaccharide enhances cytotoxicity of murine pulmonary alveolar macrophages.
Journal of immunotherapy : official journal of the Society for Biological Therapy 1991;10(1):51-6.
1990: Gatenby R A; Taylor D D
Suppression of wound healing in tumor bearing animals as a model for tumor-host interaction: mechanism of suppression.
Cancer research 1990;50(24):7997-8001.
1990: Jiang C G; Taylor D D; Black P H
Effect of retinoic acid on tumor-mediated immunologic alterations in mice bearing a variant of the B16 melanoma.
International journal of cancer. Journal international du cancer 1990;46(6):1054-8.
1990: Taylor D D; Taylor C G; Black P H; Jiang C G; Chou I N
Alterations of cellular characteristics of a human ovarian teratocarcinoma cell line after in vitro treatment with retinoids.
Differentiation; research in biological diversity 1990;43(2):123-30.
1990: Keller S M; Taylor D D; Weese J L
In vitro killing of human malignant mesothelioma by photodynamic therapy.
The Journal of surgical research 1990;48(4):337-40.
1988: Taylor D D; Taylor C G; Jiang C G; Black P H
Characterization of plasma membrane shedding from murine melanoma cells.
International journal of cancer. Journal international du cancer 1988;41(4):629-35.
1987: Devereux D F; Taylor D D; Taylor C G; Hollander D M
Effects of retinoic acid on lipolytic activity of tumor cells.
Surgery 1987;102(2):277-82.
1986: Hollander D M; Devereux D F; Taylor C G; Taylor D D
Demonstration of lipolytic activity from cultured human melanoma cells.
The Journal of surgical research 1986;40(5):445-9.
1986: Taylor D D; Black P H
Shedding of plasma membrane fragments. Neoplastic and developmental importance.
Developmental biology (New York, N.Y. : 1985) 1986;3():33-57.

Sign-in to see more